Clinical Features Associated With Poor Pharmacologic Adherence in Bipolar Disorder: Results From the STEP-BD Study

被引:91
|
作者
Perlis, Roy H. [1 ,2 ,3 ]
Ostacher, Michael J. [1 ,2 ,3 ]
Miklowitz, David J. [4 ]
Hay, Aleena [1 ,2 ,3 ]
Nierenberg, Andrew A. [1 ,2 ,3 ]
Thase, Michael E. [5 ]
Sachs, Gary S. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Bipolar Clin & Res Program, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02114 USA
[4] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA
[5] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
TREATMENT ENHANCEMENT PROGRAM; MEDICATION ADHERENCE; INCREASE ADHERENCE; LITHIUM; RISK; INDIVIDUALS; VALIDATION; PREDICTORS; ALGORITHMS; OUTCOMES;
D O I
10.4088/JCP.09m05514yel
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Poor medication adherence is common among bipolar patients. Method: We examined prospective data from 2 cohorts of individuals from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (1999-2005) with bipolar disorder. Clinical and sociodemographic features associated with missing at least 25% of doses of at least 1 medication were assessed using logistic regression, and a risk stratification model was developed and validated. Results: Of 3,640 subjects with 48,287 follow-up visits, 871 (24%) reported nonadherence on 20% or more study visits. Clinical features significantly associated (P<.05) with poor adherence included rapid cycling, suicide attempts, earlier onset of illness, and current anxiety or alcohol use disorder. Nonadherence during the first 3 months of follow-up was associated with less improvement in functioning at 12-month follow-up (P<.03). A risk stratification model using clinical predictors accurately classified 80.6% of visits in an independent validation cohort. Conclusion: Risk for poor medication adherence can be estimated and may be useful in targeting interventions. J Clin Psychiatry 2010;71(3):296-303 (C) Copyright 2010 Physicians Postgraduate Press, Inc.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 50 条
  • [1] The impact of body mass index on the clinical features of bipolar disorder: A STEP-BD study
    Kadriu, Bashkim
    Deng, Zhi-De
    Kraus, Christoph
    Johnston, Jenessa N.
    Fijtman, Adam
    Henter, Ioline D.
    Kasper, Siegfried
    Zarate Jr, Carlos A.
    BIPOLAR DISORDERS, 2024, 26 (02) : 160 - 175
  • [2] Aims and Results of the NIMH Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Bowden, C. L.
    Perlis, R. H.
    Thase, M. E.
    Ketter, T. A.
    Ostacher, M. M.
    Calabrese, J. R.
    Reilly-Harrington, N. A.
    Gonzalez, J. M.
    Singh, V.
    Nierenberg, A. A.
    Sachs, G. S.
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (03) : 243 - 249
  • [3] Do Comorbid Anxiety Disorders Moderate the Effects of Psychotherapy for Bipolar Disorder? Results From STEP-BD
    Deckersbach, Thilo
    Peters, Amy T.
    Sylvia, Louisa
    Urdahl, Anna
    Magalhaes, Pedro V. S.
    Otto, Michael W.
    Frank, Ellen
    Miklowitz, David J.
    Berk, Michael
    Kinrys, Gustavo
    Nierenberg, Andrew
    AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (02) : 178 - 186
  • [4] Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD
    Goldberg, Joseph F.
    Brooks, John O.
    Kurita, Keiko
    Hoblyn, Jennifer C.
    Ghaemi, Nassir
    Perlis, Roy H.
    Miklowitz, David J.
    Ketter, Terence A.
    Sachs, Gary S.
    Thase, Michael E.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (02) : 155 - 162
  • [5] LESSONS FROM STEP-BD FOR THE TREATMENT OF BIPOLAR DEPRESSION
    Nierenberg, Andrew A.
    DEPRESSION AND ANXIETY, 2009, 26 (02) : 106 - 109
  • [6] A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD
    Deckersbach, Thilo
    Peters, Amy T.
    Sylvia, Louisa G.
    Gold, Alexandra K.
    da Silva Magalhaes, Pedro Vieira
    Henry, David B.
    Frank, Ellen
    Otto, Michael W.
    Berk, Michael
    Dougherty, Darin D.
    Nierenberg, Andrew A.
    Miklowitz, David J.
    JOURNAL OF AFFECTIVE DISORDERS, 2016, 203 : 152 - 157
  • [7] Advancing Bipolar Disorder: Key Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
    Parikh, Sagar V.
    LeBlanc, Serge R.
    Ovanessian, Melina M.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2010, 55 (03): : 136 - 143
  • [8] Presentation and prevalence of PTSD in a bipolar disorder population: A STEP-BD examination
    Hernandez, Julia M.
    Cordova, Matthew J.
    Ruzek, Josef
    Reiser, Robert
    Gwizdowski, Iola S.
    Suppes, Trisha
    Ostacher, Michael J.
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 150 (02) : 450 - 455
  • [9] Benzodiazepine Use and Risk of Recurrence in Bipolar Disorder: A STEP-BD Report
    Perlis, Roy H.
    Ostacher, Michael J.
    Miklowitz, David J.
    Smoller, Jordan W.
    Dennehy, Ellen B.
    Cowperthwait, Colleen
    Nierenberg, Andrew A.
    Thase, Michael E.
    Sachs, Gary S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (02) : 194 - 200
  • [10] The functional impact of subsyndromal depressive symptoms in bipolar disorder: Data from STEP-BD
    Marangell, Lauren B.
    Dennehy, Ellen B.
    Miyahara, Sachiko
    Wisniewski, Stephen R.
    Bauer, Mark S.
    Rapaport, Mark Hyman
    Allen, Michael H.
    JOURNAL OF AFFECTIVE DISORDERS, 2009, 114 (1-3) : 58 - 67